• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本精神病医院死亡证明将死亡归因于阿尔茨海默病和其他痴呆症的准确性。

Accuracy of Death Certificates in Attributing Mortality to Alzheimer's Disease and Other Dementias in Japanese Psychiatric Hospitals.

作者信息

Sato Kengo, Shioda Katsutoshi, Suda Shiro

机构信息

Department of Psychiatry, Jichi Medical University, Tochigi, Japan.

Cocoro Care Center, Jichi Medical University, Tochigi, Japan.

出版信息

Neuropsychiatr Dis Treat. 2025 Jul 5;21:1325-1337. doi: 10.2147/NDT.S520892. eCollection 2025.

DOI:10.2147/NDT.S520892
PMID:40636801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12239922/
Abstract

AIM

Dementia, including Alzheimer's disease (AD), is a leading cause of mortality in Europe and the United States. Interestingly, while Japan is recognized for its high life expectancy, dementia-related diseases account for a comparatively lower proportion of recorded deaths. This study aimed to investigate the actual mortality attributed to clinically diagnosed AD in Japan, particularly in psychiatric hospital settings.

METHODS

Total 653 cases Death certificates and medical records from psychiatric hospitals in Japan were analyzed to investigate the actual death rate associated with dementia diseases.

RESULTS

In total, 134 of the 653 cases (20.5%) were determined to have AD as the direct cause of death, a significant increase from the 34 cases initially identified from death certificates alone (P<0.01). And more, after reviewing the death certificates and medical records of 653 patients, 203 (134 with AD and 69 with other dementias) were identified as having dementia as the direct cause of death, representing 31.1% of all deaths. This rate was significantly higher than the rate identified before the medical record review (P<0.01). Dementia diagnoses were frequently omitted from death certificates, with complications often recorded as the primary cause of death. This suggests that the true incidence of dementia-related mortality in Japan may be approximately four times higher than reported.

CONCLUSION

We found that the true incidence of dementia-related mortality in Japan may be higher than reported. These findings underscore the critical need to increase awareness about dementia as a cause of death and to educate the public and healthcare professionals on accurately documenting it on death certificates.

摘要

目的

痴呆症,包括阿尔茨海默病(AD),是欧美地区主要的死亡原因。有趣的是,尽管日本以高预期寿命而闻名,但与痴呆症相关的疾病在记录的死亡中所占比例相对较低。本研究旨在调查日本临床诊断为AD的实际死亡率,特别是在精神病院环境中的情况。

方法

分析了日本精神病院的653份死亡证明和病历,以调查与痴呆症相关疾病的实际死亡率。

结果

在653例病例中,共有134例(20.5%)被确定AD为直接死亡原因,这一数字较最初仅从死亡证明中确定的34例有显著增加(P<0.01)。此外,在审查了653名患者的死亡证明和病历后,有203例(134例为AD,69例为其他痴呆症)被确定痴呆为直接死亡原因,占所有死亡人数的31.1%。这一比例显著高于病历审查前确定的比例(P<0.01)。死亡证明中经常遗漏痴呆症诊断,并发症常被记录为主要死亡原因。这表明日本痴呆症相关死亡率的实际发生率可能比报告的高出约四倍。

结论

我们发现日本痴呆症相关死亡率的实际发生率可能高于报告的数字。这些发现强调了提高对痴呆症作为死亡原因的认识以及教育公众和医疗保健专业人员在死亡证明上准确记录的迫切需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/12239922/6cfd37b5e7f8/NDT-21-1325-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/12239922/6cfd37b5e7f8/NDT-21-1325-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/12239922/6cfd37b5e7f8/NDT-21-1325-g0001.jpg

相似文献

1
Accuracy of Death Certificates in Attributing Mortality to Alzheimer's Disease and Other Dementias in Japanese Psychiatric Hospitals.日本精神病医院死亡证明将死亡归因于阿尔茨海默病和其他痴呆症的准确性。
Neuropsychiatr Dis Treat. 2025 Jul 5;21:1325-1337. doi: 10.2147/NDT.S520892. eCollection 2025.
2
Sexual Harassment and Prevention Training性骚扰与预防培训
3
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
4
"It Was Like the Final Piece in the Puzzle for Me": A Qualitative Study on the Experiences of Autistic Women Initially Diagnosed with Borderline Personality Disorder.“对我来说,这就像拼图中的最后一块”:一项关于最初被诊断为边缘型人格障碍的自闭症女性经历的定性研究
Autism Adulthood. 2024 Dec 2;6(4):428-437. doi: 10.1089/aut.2023.0031. eCollection 2024 Dec.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Pharmacotherapies for sleep disturbances in dementia.痴呆症睡眠障碍的药物治疗
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.
7
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
8
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
9
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
10
Nimodipine for primary degenerative, mixed and vascular dementia.尼莫地平用于原发性退行性、混合型和血管性痴呆。
Cochrane Database Syst Rev. 2001(1):CD000147. doi: 10.1002/14651858.CD000147.

本文引用的文献

1
Senility deaths in aged societies: The case of Japan.老龄化社会中的衰老死亡:以日本为例。
Glob Health Med. 2024 Feb 29;6(1):40-48. doi: 10.35772/ghm.2023.01127.
2
Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer's Coordinating Center Uniform Data Set.阿尔茨海默病的疾病严重程度和死亡率:使用美国国家阿尔茨海默病协调中心统一数据集进行的分析。
BMC Neurol. 2023 Aug 14;23(1):302. doi: 10.1186/s12883-023-03353-w.
3
Mortality in Schizophrenia-Spectrum Disorders: Recent Advances in Understanding and Management.
精神分裂症谱系障碍中的死亡率:理解与管理的最新进展
Healthcare (Basel). 2022 Nov 25;10(12):2366. doi: 10.3390/healthcare10122366.
4
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.2019 年全球痴呆症患病率估计及 2050 年预测患病率:2019 年全球疾病负担研究分析。
Lancet Public Health. 2022 Feb;7(2):e105-e125. doi: 10.1016/S2468-2667(21)00249-8. Epub 2022 Jan 6.
5
Number of long-term inpatients in Japanese psychiatric care beds: trend analysis from the patient survey and the 630 survey.日本精神科护理床位的长期住院患者人数:来自患者调查和 630 调查的趋势分析。
BMC Psychiatry. 2020 Nov 3;20(1):522. doi: 10.1186/s12888-020-02927-z.
6
Estimates of the Association of Dementia With US Mortality Levels Using Linked Survey and Mortality Records.利用关联调查和死亡率记录估计痴呆症与美国死亡率水平的关系。
JAMA Neurol. 2020 Dec 1;77(12):1543-1550. doi: 10.1001/jamaneurol.2020.2831.
7
Medical comorbid diagnoses among adult psychiatric inpatients.成年精神科住院患者的合并医疗诊断。
Gen Hosp Psychiatry. 2020 Sep-Oct;66:16-23. doi: 10.1016/j.genhosppsych.2020.06.010. Epub 2020 Jun 23.
8
Increased risk of dementia in patients with Schizophrenia: A population-based cohort study in Taiwan.精神分裂症患者痴呆风险增加:台湾基于人群的队列研究。
Eur Psychiatry. 2018 Sep;53:7-16. doi: 10.1016/j.eurpsy.2018.05.005. Epub 2018 May 30.
9
Deaths from Alzheimer's Disease - United States, 1999-2014.1999 - 2014年美国阿尔茨海默病导致的死亡情况
MMWR Morb Mortal Wkly Rep. 2017 May 26;66(20):521-526. doi: 10.15585/mmwr.mm6620a1.
10
Mortality from Alzheimer's disease, Parkinson's disease, and dementias in France and Italy: a comparison using the multiple cause-of-death approach.法国和意大利的阿尔茨海默病、帕金森病和痴呆症的死亡率:使用多死因方法进行的比较。
J Aging Health. 2014 Mar;26(2):283-315. doi: 10.1177/0898264313514443.